A Phase 4, Single-Center, Open-Label Study Evaluating the Safety of the Tyrvaya Nasal Pump
Latest Information Update: 04 May 2025
At a glance
- Drugs Varenicline (Primary)
- Indications Dry eyes; Keratoconjunctivitis sicca
- Focus Adverse reactions
- Sponsors Oyster Point Pharmaceuticals
Most Recent Events
- 17 Apr 2024 Status changed from active, no longer recruiting to discontinued. (Internal strategy change. Not related to safety concerns.)
- 28 Mar 2024 New trial record